Skip to main content
Market icon

Casos de sarampo nos EUA até 30 de abril?

Market icon

Casos de sarampo nos EUA até 30 de abril?

abr 30

dez 31

abr 30

dez 31

Polymarket

$194,638 Vol.

Polymarket

$194,638 Vol.

1800

$52,036 Vol.

61%

1850

$5,501 Vol.

19%

1900

$50,792 Vol.

7%

1950

$20,403 Vol.

3%

2000

$42,683 Vol.

3%

2100

$7,283 Vol.

2%

2200

$15,939 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the US year-to-date across 33 jurisdictions, with 94% outbreak-associated amid 17 new outbreaks, surpassing early-year paces from prior years. Over 92% of cases involve unvaccinated or unknown-status individuals, driven by declining MMR vaccination coverage—down to 92.5% among kindergartners—and importations from international travelers seeding clusters in states like Utah (over 580 cases), South Carolina (nearly 1,000 cumulative), and Texas. Transmission persists in under-vaccinated communities despite public health interventions. Traders should watch weekly CDC updates and state surveillance reports through April 30, as ongoing chains could add hundreds more cases before resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$194,638
Data de Término
30 abr 2026
Mercado Aberto
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the US year-to-date across 33 jurisdictions, with 94% outbreak-associated amid 17 new outbreaks, surpassing early-year paces from prior years. Over 92% of cases involve unvaccinated or unknown-status individuals, driven by declining MMR vaccination coverage—down to 92.5% among kindergartners—and importations from international travelers seeding clusters in states like Utah (over 580 cases), South Carolina (nearly 1,000 cumulative), and Texas. Transmission persists in under-vaccinated communities despite public health interventions. Traders should watch weekly CDC updates and state surveillance reports through April 30, as ongoing chains could add hundreds more cases before resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$194,638
Data de Término
30 abr 2026
Mercado Aberto
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado com os links externos.

Frequently Asked Questions

"Casos de sarampo nos EUA até 30 de abril?" is a prediction market on Polymarket with 7 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "1800" at 61%, followed by "1850" at 19%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 61¢ implies that the market collectively assigns a 61% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Casos de sarampo nos EUA até 30 de abril?" has generated $194.6K in total trading volume since the market launched on Mar 24, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Casos de sarampo nos EUA até 30 de abril?," browse the 7 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Casos de sarampo nos EUA até 30 de abril?" is "1800" at 61%, meaning the market assigns a 61% chance to that outcome. The next closest outcome is "1850" at 19%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Casos de sarampo nos EUA até 30 de abril?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.